DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
van Bömmel F, Berg T.
Stopping long-term treatment with nucleos(t)ide analogues is a favourable option for selected patients with HBeAg-negative chronic hepatitis B.
Liver Int 2018;
38 (Suppl. 01) 90-96
We do not assume any responsibility for the contents of the web pages of other providers.